<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02540005</url>
  </required_header>
  <id_info>
    <org_study_id>230215-1</org_study_id>
    <nct_id>NCT02540005</nct_id>
  </id_info>
  <brief_title>Coagulation Disorders After Aneurysmatic Subarachnoid Haemorrhage</brief_title>
  <official_title>Coagulation Disorders After Aneurysmatic Subarachnoid Haemorrhage</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tampere University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>CSL Behring</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Tampere University Hospital</source>
  <brief_summary>
    <textblock>
      The main purpose of this study is to analyse the on-going coagulation process after aSAH. For
      investigation the investigators use the rotational thromboelastometry (ROTEM) which is a
      point-of-care test using a variety of activators to provide a targeted and a dynamic analysis
      of coagulation cascade. This is a prospective, observational clinical study done in 16 aSAH
      patients treated in Tampere University Hospital intensive care unit and 16 control patients
      (elective craniotomy due to non-ruptured intracranial aneurysm.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2015</start_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>ROTEM analysis: MCF (mm) by EXTEM activators</measure>
    <time_frame>12 hours</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">32</enrollment>
  <condition>Aneurysmatic Subarachnoid Haemorrhage</condition>
  <arm_group>
    <arm_group_label>Aneurysmatic subarachnoid haemorrhage</arm_group_label>
    <description>Acute subarachnoid haemorrhage (confirmed by computed tomography, CT, or cerebrospinal fluid erythrocyte count over 1000 x 106/l) AND confirmed origin either with computed angiography (CTA) or digital subtraction angiography (DSA)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control patients</arm_group_label>
    <description>Elective craniotomy due to non-ruptured intracranial aneurysm</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ROTEM analysis</intervention_name>
    <arm_group_label>Aneurysmatic subarachnoid haemorrhage</arm_group_label>
    <arm_group_label>Control patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Acute aneurysmal subarachnoid haemorrhage patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 18 years

          -  Acute subarachnoid haemorrhage (confirmed by computed tomography, CT, or cerebrospinal
             fluid erythrocyte count over 1000 x 106/l) AND confirmed origin either with computed
             angiography (CTA) or digital subtraction angiography (DSA)

          -  Onset of symptoms ≤ 12 hours

          -  Expected to stay 72 hours in the ICU

        Exclusion Criteria:

          -  Pregnancy

          -  Any long-term anticoagulant medication, except for low-dose aspirin (&lt;150 mg/day)

          -  Known active cancer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <state>Pirkanmaa</state>
        <zip>33521</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 1, 2015</study_first_submitted>
  <study_first_submitted_qc>September 2, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 3, 2015</study_first_posted>
  <last_update_submitted>June 27, 2016</last_update_submitted>
  <last_update_submitted_qc>June 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tampere University Hospital</investigator_affiliation>
    <investigator_full_name>Annukka Vahtera</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
    <mesh_term>Blood Coagulation Disorders</mesh_term>
    <mesh_term>Hemostatic Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

